ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
Approved
DIN Number
02516675
Drug Class
Human
Market Date
N/A
Company
HC
Fresenius Kabi AG
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02516675
AIG Number0300464004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Ethical
A
ATC Code
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Product Specifications
Dosage FormSolution
Route of Administration0-Unassigned
AHFS Classification20:12.04.92
Health Canada Classification
ACTIVE INGREDIENTS (3)
CITRIC ACIDActive
Strength: 770 MG / 100 ML
Monograph: CITRIC ACID
DEXTROSEActive
Strength: 2.54 G / 100 ML
Monograph: DEXTROSE
SODIUM CITRATEActive
Strength: 2.14 G / 100 ML
Monograph: SODIUM CITRATE